The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
c/o Steve Hanson, President
5902 Marcie Court
Garland, TX 75044-4958 USA
The Alveolar Capillary Dysplasia Association (ACDA) is a non-profit organization dedicated to providing information, support, and resources to parents of children born with alveolar capillary dysplasia (ACD). ACD is a condition characterized by abnormal development (dysplasia) of the tiny air sacs in the lungs (alveoli). In all reported cases, ACD has occurred in association with primary pulmonary hypertension of the newborn (PPHN), which is characterized by abnormally increased blood pressure in the arteries supplying the lungs. Affected infants also typically have misalignment of pulmonary veins, poor development of certain capillaries, and/or other findings. In most cases, during the first days of life, affected newborns develop a bluish discoloration of the skin and mucous membranes (cyanosis) due to abnormally low levels of circulating oxygen (hypoxia), and experience difficulty breathing. In many cases, life-threatening complications may result within three to four weeks. The condition usually appears to occur randomly, for no apparent reason (sporadic). However, a few familial cases have been reported. The Alveolar Capillary Dysplasia Association was established in 1997 by the parents of a child born with ACD. The association is committed to providing mutual support to affected families through networking services; offering information concerning current research; educating the medical community and the general public about alveolar capillary dysplasia; and working with affected families and the medical community to expand the current knowledge of ACD.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.